# US 2024/0174654 A1 · Process for the preparation of a cyp11a1 inhibitor and intermediates thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0174654 A1
- Document ID: US20240174654A1
- Status: Published application
- Kind: A1
- Application number: 18/548,486
- Filed: 2022-02-28
- Published: 2024-05-30
- Earliest claimed: 2021-03-01
- Assignees: Orion Corporation
- Applicants: Orion Corporation
- Inventors: Oskari Karjalainen
- Web page: https://patentgrep.com/patent/US20240174654A1

## CPC

- C07D 405/14: containing three or more hetero rings
- C07D 211/96: Sulfur atom
- C07D 211/98: Nitrogen atom
- C07D 309/32: having two double bonds between ring members or between ring members and non-ring members
- C07D 309/40: Oxygen atoms attached in positions 3 and 4, e.g. maltol
- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention relates to an improved process for the preparation of 4H-pyranone structured CYP11A1 inhibitors such as 2-(isoindolin-2-ylmethyl)-5-((1-(methylsulfonyl)piperidin-4-yl)methoxy)-4H-pyran-4-one (1A) and key intermediates thereof such as 2-(chloromethyl)-5-hydroxy-4H-pyran-4-one (II), 5-hydroxy-2-(isoindolin-2-ylmethyl)-4H-pyran-4-one (III), (1-(methylsulfonyppiperidin-4-yHmethyl methane sulfonate (V) and (1-(methyl-sulfonyppiperidin-4-yHmethyl 4-methylbenzene fonate (V″). CYP11A1 inhibitors are useful in the treatment of hormonally regulated cancers, such as prostate cancer and breast cancer.

## Claims

### Claim 1

A process for the preparation of a compound of formula (1A) or a pharmaceutically acceptable salt thereof
comprising the steps of either
a) reacting a compound of formula (III)
with a compound of formula (V)
wherein LG is a leaving group selected from a mesyl or a tosyl group, in sulfolane in the presence of cesium carbonate;
b) adding acetone and water to the mixture; and
c) isolating the compound of formula (1A), and optionally converting it to its pharmaceutically acceptable salt;
or
a′) reacting a compound of formula (III)
with a compound of formula (V)
wherein LG is a leaving group selected from a mesyl or a tosyl group,
in dimethyl sulfoxide or dimethyl formamide in the presence of cesium carbonate and tris[2-(2-methoxyethoxy)ethyl]amine);
b′) adding isopropanol and water to the mixture; and
c′) isolating the compound of formula (1A), and optionally converting it to its pharmaceutically acceptable salt.

### Claim 2 (depends on 1)

A process according to claim 1 comprising the steps of
a) reacting a compound of formula (III)
with a compound of formula (V)
wherein LG is a leaving group selected from a mesyl or a tosyl group, in sulfolane in the presence of cesium carbonate;
b) adding acetone and water to the mixture; and
c) isolating the compound of formula (1A), and optionally converting it to its pharmaceutically acceptable salt.

### Claim 3 (depends on 1)

The process of claim 1, wherein the reaction temperature at step a) is from about 70 to about 90° C.

### Claim 4 (depends on 1)

The process of claim 1, wherein step b) is carried out by adding acetone followed by water.

### Claim 5 (depends on 1)

The process of claim 1, wherein the ratio acetone to water at step b) is from about 1:1 to about 1:3 per volume.

### Claim 6 (depends on 1)

The process of claim 1, wherein the temperature after step b) is from about 45° C. to about 60° C.

### Claim 7 (depends on 1)

The process of claim 1, wherein before step c) the mixture is cooled to a temperature form about 5° C. to about 25° C.

### Claim 8 (depends on 1)

The process according to claim 1 comprising the steps of
a′) reacting a compound of formula (III)
with a compound of formula (V)
wherein LG is a leaving group selected from a mesyl or a tosyl group, in dimethyl sulfoxide or dimethyl formamide in the presence of cesium carbonate and tris[2-(2-methoxyethoxy)ethyl]amine);
b′) adding isopropanol and water to the mixture; and
c′) isolating the compound of formula (1A), and optionally converting it to its pharmaceutically acceptable salt.

### Claim 9 (depends on 8)

The process according to claim 8, wherein step a′) is carried out in dimethyl sulfoxide.

### Claim 10 (depends on 8)

The process according to claim 8, wherein the reaction temperature at step a′) is from about 50° C. to about 70° C.

### Claim 11 (depends on 8)

The process according to claim 8, wherein step b′) is carried out by adding isopropanol followed by water.

### Claim 12 (depends on 8)

The process according to claim 8, wherein the ratio of isopropanol to water at step b′) is from about 1:1 to about 1:3 per volume.

### Claim 13 (depends on 9)

The process according to claim 9, wherein before step c′) the mixture is cooled to a temperature which is form about 5 to about 25° C.

### Claim 14 (depends on 8)

The process according to claim 8, wherein step a′) is carried out in dimethyl formamide.

### Claim 15 (depends on 14)

The process according to claim 14, wherein the reaction temperature at step a′) is from about 65° C. to about 75° C.

### Claim 16 (depends on 14)

The process according to claim 14, wherein step b′) is carried out by adding isopropanol followed by water.

### Claim 17 (depends on 14)

The process according to claim 14, wherein the ratio of isopropanol to water at step b′) is from about 1:1 to about 1:3 per volume.

### Claim 18 (depends on 14)

The process according to claim 14, wherein the temperature after step b′) is from about 40° C. to about 60° C.

### Claim 19 (depends on 14)

The process according to claim 14, wherein before step c′) the mixture is cooled to a temperature which is form about 10° C. to about 30° C.

### Claim 20

A process for the preparation of a compound of formula (III)
comprising the steps of either
a) reacting a compound of formula (II)
with isoindoline hydrochloride in water in the presence of potassium hydroxide;
b) transferring the reaction mixture of step a) into a mixture of acetone and acetic acid; and
c) isolating the compound of formula (III);
or
a′) reacting a compound of formula (II)
with isoindoline hydrochloride in dimethyl sulfoxide in the presence of N,N-diisopropylethylamine;
b′) adding acetonitrile and water to the mixture; and
c′) isolating the compound of formula (III).

### Claim 21 (depends on 20)

The process according to claim 20 comprising the steps of
a) reacting a compound of formula (II)
with isoindoline hydrochloride in water in the presence of potassium hydroxide;
b) transferring the reaction mixture of step a) into a mixture of acetone and acetic acid;
and
c) isolating the compound of formula (III).

### Claim 22 (depends on 21)

The process according to claim 21, wherein the reaction temperature at step a) is from about 0° C. to about 20° C.

### Claim 23 (depends on 21)

The process according to claim 21, wherein the ratio of acetone to acetic acid at step b) is from about 10:1 to about 6:1 per volume.

### Claim 24 (depends on 21)

The process according to claim 21, wherein the temperature after step b) is from about 30° C. to about 40° C.

### Claim 25 (depends on 20)

The process according to claim 20 comprising the steps of
a′) reacting a compound of formula (II)
with isoindoline hydrochloride in dimethyl sulfoxide in the presence of N,N-diisopropylethylamine;
b′) adding acetonitrile and water to the mixture; and
c′) isolating the compound of formula (III).

### Claim 26 (depends on 25)

The process according to claim 25, wherein the reaction temperature at step a′) is from about 40° C. to about 60° C.

### Claim 27 (depends on 25)

The process according to claim 25, wherein the ratio of acetonitrile to water at step b′) is from about 1:1 to about 1:3 per volume.

### Claim 28 (depends on 25)

The process according to claim 25, wherein step b′) further comprises addition of acetic acid.

### Claim 29 (depends on 25)

The process according to claim 25, wherein the temperature after step b′) is from about 40° C. to about 60° C.

### Claim 30 (depends on 25)

The process according to claim 25, wherein before step c′) the mixture is cooled to a temperature which is form about 10° C. to about 30° C.

### Claim 31 (depends on 20)

The process according to claim 20, wherein the compound of formula (II) is prepared by reacting a compound of formula (I)
with thionyl chloride in acetonitrile, adding water, and isolating the compound of formula (II).

### Claim 32

A process for the preparation of a compound of formula (II)
comprising the steps of
a) reacting a compound of formula (I)
with thionyl chloride in acetonitrile;
b) adding water; and
c) isolating the compound of formula (II).

### Claim 33

A process for the preparation of a compound of formula (V′)
comprising the steps of
a) reacting a compound of formula (IV)
with methanesulfonyl chloride in acetonitrile-pyridine solvent;
b) adding water and acetic acid to the mixture; and
c) isolating the compound of formula (V′).

### Claim 34 (depends on 33)

The process according to claim 33, wherein the reaction temperature at step a) is from about 25° C. to about 50° C.

### Claim 35 (depends on 33)

The process according to claim 33, wherein the ratio of acetonitrile to pyridine at step a) is from about 1:2 to about 2:1 per volume.

### Claim 36 (depends on 33)

The process according to claim 33, wherein step b) is carried out by adding water followed by acetic acid.

### Claim 37 (depends on 33)

The process according to claim 33, wherein the ratio of water to acetic acid at step b) is from about 5:1 to about 10:1 per volume.

### Claim 38 (depends on 33)

The process according to claim 33, wherein before step c) the mixture is cooled to a temperature which is form about −10 to about 10° C.

### Claim 39

A process for the preparation of a compound of formula (V″)
comprising the steps of
a) reacting a compound of formula (IV)
with chlorotrimethylsilane to obtain compound of formula (IVb)
b) reacting the compound of formula (IVb) with methanesulfonyl chloride to obtain a compound of formula (IVc)
c) treating the compound of formula (IVc) with p-toluenesulfonic acid in the presence of methanol to obtain a compound of formula (IVd)
and
d) reacting the compound of formula (IVd) with p-toluenesulfonyl chloride to obtain the compound of formula (V″).

### Claim 40 (depends on 39)

The process according to claim 39, wherein step a) is carried out in the presence of 1,1,3,3-tetramethylguanidine.

### Claim 41 (depends on 39)

The process according to claim 39, wherein step b) is carried out in the presence of N-methylmorpholine.

### Claim 42 (depends on 39)

The process according to claim 39, wherein step d) is carried out in the presence of pyridine.

### Claim 43

A process for the preparation of a compound of formula (1A) or a pharmaceutically acceptable salt thereof
comprising the steps of either
a) reacting a compound of formula (II)
with isoindoline hydrochloride in water in the presence of potassium hydroxide;
b) transferring the reaction mixture of step a) into a mixture of acetone and acetic acid;
and
c) isolating the compound of formula (III);
or
a′) reacting a compound of formula (II)
with isoindoline hydrochloride in dimethyl sulfoxide in the presence of N,N-diisopropylethylamine;
b′) adding acetonitrile and water to the mixture; and
c′) isolating the compound of formula (III);
d) either reacting a compound of formula (III)
with a compound of formula (V)
wherein LG is a leaving group selected from a mesyl or a tosyl group,
in sulfolane in the presence of cesium carbonate;
e) adding acetone and water to the mixture; and
f) isolating the compound of formula (1A), and optionally converting it to its pharmaceutically acceptable salt;
or
d′) reacting a compound of formula (III)
with a compound of formula (V)
wherein LG is a leaving group selected from a mesyl or a tosyl group,
in dimethyl sulfoxide or dimethyl formamide in the presence of cesium carbonate and tris[2-(2-methoxyethoxy)ethyl]amine);
e′) adding isopropanol and water to the mixture; and
f′) isolating the compound of formula (1A), and optionally converting it to its pharmaceutically acceptable salt.
